This is also the first study, toour knowledge, which validates the use of specific Notch1, Hes1, and Ascl1antibodies on human SCLC samples, and tries to find cut-offs for low vs highexpression based on a biological and clinical rationale. The gene discussed is NOTCH1; the disease is small cell lung carcinoma.